Mizuho Reiterates Buy Rating on ICON Public Limited Company
Mizuho maintains its buy rating on ICON with a $190 price target, a 9.83% upside from the current price.
Key Points
- Mizuho reiterated its buy rating on ICON Public Limited Company (ICLR) with a $190 price target on June 26, 2026.
- Mizuho's $190 price target implies 9.83% upside from ICON Public Limited Company's ($ICLR) current $172.99 share price.
- Shares of ICLR traded near $160.96 on Friday, with a market cap of $12.3 billion and a forward P/E of 13.6.
- Other analysts, including Citigroup and BMO Capital, also maintained ratings, with price targets ranging from $165 to $197.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 26, 2026, Mizuho reiterated its buy rating on ICON Public Limited Company (NasdaqGS: ICLR), setting a price target of $190. This reflects continued confidence in the company's prospects.
Mizuho vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
ICON Public Limited Company Stock Up 1.7%
Shares of ICON Public Limited Company traded near $160.96 on Friday. The company has a market cap of about $12.3 billion. It has a P/E ratio of 70.9 and a forward P/E of 13.6, indicating expectations of future earnings growth. ICON's stock has seen a 52-week low of $66.57 and a high of $211.00. The stock's 50-day moving average is $127.80, and its 200-day moving average is $149.18. ICON maintains a current ratio of 1.14 and a quick ratio of 1.09, with a debt-to-equity ratio of 37.72.
$ICLR price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Recent Earnings
In its recent earnings report, ICON Public Limited Company reported revenue of approximately $8.27 billion, with a growth rate of 1.6%. The company's net margin stands at 2.1%, and return on equity is 1.84%. The EPS was $2.27. The next earnings announcement is expected on June 23, 2026.
Insider Buying and Selling at ICON Public Limited Company
On May 14, 2026, several insiders made transactions involving ICON shares. Dr. John Climax bought 5,005 shares, while Ronan Martin Murphy and Eugene Pacelli McCague each sold 5,005 and 3,255 shares, respectively. These transactions were not part of any pre-planned trading program.
Analysts Set New Price Targets
On June 26, 2026, Mizuho maintained its buy rating on ICON with a $190 price target. Other analysts have also weighed in recently: Citigroup maintained a hold rating with a $165 target, BMO Capital maintained a buy with a $187 target, and RBC Capital upgraded to buy with a $185 target. The consensus among 16 analysts is a buy recommendation, with an average target price of $175.31.
About ICON Public Limited Company
ICON Public Limited Company, headquartered in Dublin, Ireland, is a global clinical research organization. It provides outsourced development and commercialization services, specializing in clinical development from early stages to post-market. With about 40,100 employees, ICON offers a range of services including clinical trial management, consulting, and laboratory services. The company serves pharmaceutical, biotechnology, and medical device industries worldwide.
Bottom Line
Mizuho's reiteration of its buy rating for ICON Public Limited Company highlights ongoing confidence in the company's strategic direction. With a new target price of $190, investors are watching ICON's performance closely. While 13F filings provide a backward-looking view, they remain a key tool for gauging institutional sentiment.
Get ICON Public Limited Company alerts
New 13F filings, insider trades, and analyst moves on $ICLR, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.